Evogene (Israel) Market Value
| EVGN Stock | ILA 599.80 0.20 0.03% |
| Symbol | Evogene |
Evogene 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Evogene's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Evogene.
| 12/03/2023 |
| 11/27/2024 |
If you would invest 0.00 in Evogene on December 3, 2023 and sell it all today you would earn a total of 0.00 from holding Evogene or generate 0.0% return on investment in Evogene over 360 days. Evogene is related to or competes with Compugen, Kamada, BioLine RX, Enlivex Therapeutics, and Evogene. Evogene Ltd., together with its subsidiaries, operates as a computational biology company More
Evogene Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Evogene's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Evogene upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.39) | |||
| Maximum Drawdown | 30.28 | |||
| Value At Risk | (9.43) | |||
| Potential Upside | 5.18 |
Evogene Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Evogene's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Evogene's standard deviation. In reality, there are many statistical measures that can use Evogene historical prices to predict the future Evogene's volatility.| Risk Adjusted Performance | (0.27) | |||
| Jensen Alpha | (1.68) | |||
| Total Risk Alpha | (2.48) | |||
| Treynor Ratio | 4.34 |
Evogene Backtested Returns
Evogene secures Sharpe Ratio (or Efficiency) of -0.31, which denotes the company had a -0.31% return per unit of risk over the last 3 months. Evogene exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Evogene's Standard Deviation of 4.75, variance of 22.53, and Mean Deviation of 3.21 to check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.4, which means possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Evogene are expected to decrease at a much lower rate. During the bear market, Evogene is likely to outperform the market. At this point, Evogene has a negative expected return of -1.5%. Please make sure to confirm Evogene's maximum drawdown, potential upside, and the relationship between the treynor ratio and value at risk , to decide if Evogene performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.33 |
Below average predictability
Evogene has below average predictability. Overlapping area represents the amount of predictability between Evogene time series from 3rd of December 2023 to 31st of May 2024 and 31st of May 2024 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Evogene price movement. The serial correlation of 0.33 indicates that nearly 33.0% of current Evogene price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.33 | |
| Spearman Rank Test | 0.34 | |
| Residual Average | 0.0 | |
| Price Variance | 437 K |
Evogene lagged returns against current returns
Autocorrelation, which is Evogene stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Evogene's stock expected returns. We can calculate the autocorrelation of Evogene returns to help us make a trade decision. For example, suppose you find that Evogene has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Evogene regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Evogene stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Evogene stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Evogene stock over time.
Current vs Lagged Prices |
| Timeline |
Evogene Lagged Returns
When evaluating Evogene's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Evogene stock have on its future price. Evogene autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Evogene autocorrelation shows the relationship between Evogene stock current value and its past values and can show if there is a momentum factor associated with investing in Evogene.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Evogene Stock
When determining whether Evogene offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evogene's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evogene Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evogene Stock:Check out Evogene Correlation, Evogene Volatility and Evogene Alpha and Beta module to complement your research on Evogene. For information on how to trade Evogene Stock refer to our How to Trade Evogene Stock guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Evogene technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.